Elena Boldrin
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 6
- Cancer therapeutics and mechanisms 2
- Cell death mechanisms and regulation 2
- RNA Research and Splicing 2
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
- Co-authors
- Klaus‐Michael Debatin (7 shared papers)Geertruy te Kronnie (7 shared papers)Silvia Bresolin (5 shared papers)Stefania Bortoluzzi (6 shared papers)Enrico Gaffo (5 shared papers)Chiara Frasson (1 shared paper)Luca Trentin (2 shared papers)Cristiano De Pittà (1 shared paper)
In The Last Decade
Elena Boldrin
13 papers receiving 211 citations
Peers
Comparison fields: 5 of 36
- Cancer Research 120
- Molecular Biology 160
- Hematology 25
- Oncology 25
- Public Health, Environmental and Occupational Health 25
Countries citing papers authored by Elena Boldrin
This map shows the geographic impact of Elena Boldrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Boldrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Boldrin more than expected).
Fields of papers citing papers by Elena Boldrin
This network shows the impact of papers produced by Elena Boldrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Boldrin. The network helps show where Elena Boldrin may publish in the future.
Co-authors
The 25 scholars most cited alongside Elena Boldrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 75 | |
| 2 | 2019 | 32 | |
| 3 | 2020 | 26 | |
| 4 | 2015 | 25 | |
| 5 | 2019 | 16 | |
| 6 | 2022 | 9 | |
| 7 | 2019 | 9 | |
| 8 | 2022 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2018 | 4 | |
| 11 | 2019 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2019 | 1 | |
| 14 | 2023 | 0 |
About Elena Boldrin
Elena Boldrin is a scholar working on Molecular Biology, Cancer Research, Public Health, Environmental and Occupational Health, Oncology and Hematology, having authored 14 papers that have together received 211 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer therapeutics and mechanisms (2 papers), Cell death mechanisms and regulation (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (120 citations), Molecular Biology (160 citations), Hematology (25 citations), Oncology (25 citations) and Public Health, Environmental and Occupational Health (25 citations). Elena Boldrin has collaborated with scholars based in Germany, Italy and Sweden. Frequent co-authors include Klaus‐Michael Debatin, Geertruy te Kronnie, Silvia Bresolin, Stefania Bortoluzzi, Enrico Gaffo, Chiara Frasson, Luca Trentin, Cristiano De Pittà, Gianni Bisogno and Angelo Rosolen. Their work appears in journals such as Blood Advances, Haematologica, Scientific Reports, HemaSphere and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.